Drugs / iMP cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03515291 | Jan 2020 → Jan 2021 | — | Cell Therapy Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iMP cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03515291 ↗ |
| Modality | Cell therapy | “iMP cells were developed by the sponsor as an allogeneic mesodermally derived cellular therapy for cardiac conditions” NCT03515291 ↗ |